Target intelligence / Profile preview

No conventional drug-like molecular target

Molecular classification
Other
01

Overview

The classification "No conventional drug-like molecular target" refers to therapeutic agents that do not exert their pharmacological effects through interaction with a specific biological macromolecule, such as a receptor, enzyme, or ion channel. Instead, these agents typically function through non-specific physical or chemical mechanisms (ChEMBL, 2024). For example, antacids like calcium carbonate work by directly neutralizing gastric acid, while osmotic laxatives like magnesium sulfate create an osmotic gradient to retain water in the intestinal lumen (Goodman & Gilman's, 2023). Other examples include activated charcoal, which adsorbs toxins in the gastrointestinal tract, and simethicone, which alters the surface tension of gas bubbles to facilitate their expulsion. Because these substances lack a defined protein binding site, they do not follow traditional receptor-mediated pharmacodynamics and are often excluded from standard target-based drug discovery efforts. Safety concerns associated with these agents often involve systemic electrolyte disturbances or the non-specific interference with the absorption of other co-administered medications.

Other names
Non-specific mechanismPhysical/chemical actionUnknown molecular targetNon-protein target
02

Mechanism of action

Therapeutic effect achieved through physical properties (e.g., osmosis, adsorption, surface tension alteration) or simple chemical reactions (e.g., acid-base neutralization) rather than binding to a specific protein receptor, enzyme, or transporter.

03

Biological functions

Other
04

Disease associations

Gastrointestinal disordersPoisoningOther
05

Safety considerations

Electrolyte imbalanceDrug-drug interactions via malabsorptionMetabolic alkalosisNon-specific systemic effects
06

Interacting drugs

Magnesium hydroxide

4 more in the full profile.

Beyond the preview

Go deeper on No conventional drug-like molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No conventional drug-like molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call